1. Type of Securities | Registered convertible preferred stock | |
2. Method of issuance | Allotment to the 3rd Party | |
3. Details of Issuance | Number of Shares to be Issued | 4,448,760 |
Total aomunt of shares to be issued(KRW) | 45,599,790,000 | |
Date of Board of Directors' Resolution (Decision Date) | 2022-05-23 | |
Total Number of Outstanding Shares | 4,448,760 | |
Real Amount Of Issue(KRW) | 45,599,790,000 | |
Payment Date | 2022-05-31 | |
4. To be listed | No | |
5. Other references concerning investment decisions | - | |
※Title and date of other disclosure related to this one | 2022-05-31 Results of issuance(Voluntary Disclosure)(제3자배정-전환우선주) |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bridge Biotherapeutics Inc. published this content on 31 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 May 2022 08:59:08 UTC.